Trial of restorative vascular access conduit reaches 50% enrolment
Xeltis has announced that it has exceeded 50% enrolment in its US pivotal trial for aXess, its restorative vascular access conduit for haemodialysis treatment.
The...
Fluidx Medical announces novel embolic gel used to treat large RCC tumour
Fluidx Medical Technology has announced that its Ultra embolic device was most recently used to treat a large, right-sided renal cell carcinoma (RCC) tumour...
First patient enrolled in study of retrievable scaffold system in complex CLTI cohorts
Reflow Medical has announced that the Medical University of Graz (Graz, Austria) has enrolled the first patient in the DEEPER CHALLENGE clinical trial.
The investigator-initiated,...
Three-year DETOUR2 results demonstrate sustained limb preservation in complex SFA disease
Endologix today announced publication of 36-month results from the DETOUR2 clinical trial evaluating percutaneous transmural arterial bypass (PTAB) using the Detour system in the...
